Clinical Trial Update: Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a precision medicine approach for early dementia and mild cognitive impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia

Snippet

Sponsor: Alzheimer's Prevention and Reversal Project, Inc. | Conditions: Mild Cognitive Impairment, Dementia, Mild | Phase 3 | Status: COMPLETED